Injective Protocol, symbolised by INJ, has been making significant strides in the crypto space. With numerous price predictions and investment conversations trending, this blockchain protocol built for decentralized finance (DeFi) appears to be a burgeoning investment avenue. Major corporations like
Deutsche Telekom have backed the token, indicating big players are acknowledging its success and potential.
Pineapple Financial has also reportedly launched the first corporate INJ Treasury, investing an impressive $100M. Canary Capital continues to be extremely bullish on INJ, filing for a staked
ETF, suggesting a growing interest in altcoin funds. Analysts predict the price of INJ could reach a staggering new all-time high, with some speculating it could hit $100. Notably, Injective has also captured the attention of Wall Street with a $100M public treasury launch and
Cboe filing to list their staked INJ ETF. Additionally, the
XRP token has recently been integrated into the Injective platform. INJ has been tested for EVM compatibility and reportedly has the potential to rise by 130%. Among major upgrades and partnerships, INJ got listed on Indodax, while SVM Sonic teamed up with Injective to launch a crosschain AI agent hub. Stellar predictions, advancements, and a promising future bolster the argument for INJ's long-term value and potential profitability.
Injective Coin News Analytics from Tue, 27 Jul 2021 07:00:00 GMT to Thu, 11 Sep 2025 15:34:00 GMT -
Rating 6
- Innovation 8
- Information 8
- Rumor -2
